Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings (NUTX)
NASDAQ:NUTX
Clinigence Holdings (NUTX) Stock Price & Analysis
178 Followers
NUTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.16 - $67.95
Previous Close$5.05
Volume125.45K
Average Volume (3M)29.93K
Market Cap
$28.44M
Enterprise Value$284.49M
Total Cash (Recent Filing)$30.01M
Total Debt (Recent Filing)$272.39M
Price to Earnings (P/E)―
Beta2.49
Next Earnings
Aug 19, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.13
Shares Outstanding49,719,375
10 Day Avg. Volume209,959
30 Day Avg. Volume29,930
Standard Deviation0.32
R-Squared0.07
Alpha-0.16
Financial Highlights & Ratios
Price to Book (P/B)1.08
Price to Sales (P/S)0.11
Price to Cash Flow (P/CF)2.30
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit1.15
Enterprise Value/Ebitda21.75
Forecast
1Y Price Target
$5.00Price Target Upside-12.59% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Clinigence Holdings News
PremiumCompany Announcements
Clinigence Holdings Appoints Scott J. Saunders as Director
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NUTX FAQ
What was Clinigence Holdings’s price range in the past 12 months?
Clinigence Holdings lowest stock price was $4.16 and its highest was $67.95 in the past 12 months.
What is Clinigence Holdings’s market cap?
Currently, no data Available
When is Clinigence Holdings’s upcoming earnings report date?
Clinigence Holdings’s upcoming earnings report date is Aug 19, 2024 which is in 34 days.
How were Clinigence Holdings’s earnings last quarter?
Clinigence Holdings released its earnings results on May 08, 2024. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.1.
Is Clinigence Holdings overvalued?
According to Wall Street analysts Clinigence Holdings’s price is currently Overvalued.
Does Clinigence Holdings pay dividends?
Clinigence Holdings does not currently pay dividends.
What is Clinigence Holdings’s EPS estimate?
Clinigence Holdings’s EPS estimate is -$0.29.
How many shares outstanding does Clinigence Holdings have?
Clinigence Holdings has 4,971,938 shares outstanding.
What happened to Clinigence Holdings’s price movement after its last earnings report?
Clinigence Holdings reported an EPS of -$0.1 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went up 2.009%.
Which hedge fund is a major shareholder of Clinigence Holdings?
Among the largest hedge funds holding Clinigence Holdings’s share is Highbridge Capital Management LLC. It holds Clinigence Holdings’s shares valued at 3M.
---
Clinigence Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (-12.59% Downside)
$5.00 (-12.59% Downside)
Blogger Sentiment
Bullish
NUTX Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $61.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.39%
12-Months-Change
Fundamentals
Return on Equity
-52.69%
Trailing 12-Months
Asset Growth
-6.00%
Trailing 12-Months
Company Description
Clinigence Holdings
Clinigence Holdings, Inc. is a healthcare information technology company. It provides cloud-based platform that enables healthcare organizations to provide value-based care and population health management. The company was founded in 2018 and is headquartered in Atlanta, GA.
---
NUTX Stock 12 Month Forecast
Average Price Target
$5.00
▼(-12.59% Downside)
Technical Analysis
Best Analysts Covering NUTX
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-79.23%
reiterated a buy rating 2 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -79.23% per trade.
---